"Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality." JAMA Network Open 7.8 (2024): e2423385

Comprehensive Medical Screening: Clinicians should evaluate for: Thyroid nodules or goiter : Baseline neck examination and review of recent thyroid ultrasound if clinically indicated Personal or family history of thyroid cancer : Particularly medullary thyroid carcinoma Comorbid conditions : Type 2 diabetes, cardiovascular disease, pancreatitis history Gastrointestinal disorders : Severe gastroparesis (potential contraindication) Renal function : Use caution in patients at risk for volume depletion/renal impairment Psychiatric conditions : Depression, eating disorders Pregnancy status : These medications are not recommended during pregnancy and should be discontinued when pregnancy is recognized Laboratory Assessment: Baseline testing should include: TSH and free T4 Comprehensive metabolic panel (renal and hepatic function) Lipid panel Hemoglobin A1c (if diabetic or prediabetic) Routine calcitonin screening or thyroid ultrasound is not recommended solely for GLP-1 therapy initiation

Find Balance At the end of the day, the best diet for you is the one you can stick tothis means using a sustainable approach to losing weight with foods you actually enjoy eating
However, rebound weight gain during a taper-off period is frustrating and avoidable
According to a study published in the Journal of Nutrition and Metabolism, foods high in protein, along with fiber and healthy fats, can help stimulate the release of GLP-1